United Therapeutics Corporation (UTHR)

United Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts that cover United Therapeutics stock have a consensus rating of "Buy" and an average price target of $495.08, which forecasts a 3.54% increase in the stock price over the next year. The lowest target is $330 and the highest is $600.

Price Target: $495.08 (+3.54%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$330	$495.08	$525	$600
Change	-30.98%	+3.54%	+9.80%	+25.49%

* Price targets were last updated on Nov 6, 2025.

Analyst Ratings

The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	6	6	6	6	4	4
Buy	3	3	5	5	4	4
Hold	4	4	4	5	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	15	16	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ashwani Verma UBS	UBS	Strong Buy Maintains $580 → $600	Strong Buy	Maintains	$580 → $600	+25.49%	Nov 6, 2025
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $500 → $525	Strong Buy	Maintains	$500 → $525	+9.80%	Oct 30, 2025
Lisa Walter RBC Capital	RBC Capital	Buy Maintains $569 → $587	Buy	Maintains	$569 → $587	+22.77%	Oct 30, 2025
Benjamin Burnett Wells Fargo	Wells Fargo	Hold Maintains $414 → $423	Hold	Maintains	$414 → $423	-11.53%	Oct 30, 2025
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Maintains $328 → $435	Hold	Maintains	$328 → $435	-9.02%	Oct 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.27B

Increased by 13.64%

from 2.88B

Revenue Next Year

3.46B

Increased by 5.78%

from 3.27B

EPS This Year

27.61

Increased by 12.05%

from 24.64

EPS Next Year

29.75

Increased by 7.78%

from 27.61

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.48B	1.69B	1.94B	2.33B	2.88B	3.27B	3.46B
Revenue Growth	2.38%	13.63%	14.88%	20.20%	23.63%	13.64%	5.78%
EPS	11.54	10.06	15.00	19.81	24.64	27.61	29.75
EPS Growth	-	-12.83%	49.11%	32.07%	24.38%	12.05%	7.78%
Forward PE	-	-	-	-	-	17.32	16.07
No. Analysts	-	-	-	-	-	18	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	3.4B	3.7B
Avg	3.3B	3.5B
Low	3.1B	3.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	18.5%	13.9%
Avg	13.6%	5.8%
Low	7.4%	-7.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	29.53	34.16
Avg	27.61	29.75
Low	24.67	25.17

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	19.8%	23.7%
Avg	12.0%	7.8%
Low	0.1%	-8.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.